Clinical Trial Update: Pre Operative Trastuzumab in Operable Breast Cancer [Phase 3]

View source ↗

Summary

This document notes a Phase 3 clinical trial evaluating preoperative trastuzumab in operable, HER2-positive breast cancer (Stage I) that is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)

Snippet

Sponsor: Dr Rajendra A. Badwe | Conditions: Carcinoma Breast Stage I, HER2 Positive Breast Cancer | Phase 3 | Status: RECRUITING